Biomarin pharmaceutical inc (BMRN)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
REVENUES:
Total revenues

502,069

454,443

461,097

387,763

400,745

353,214

391,706

372,845

373,447

358,305

334,148

317,448

303,745

300,091

279,896

300,131

236,736

227,936

208,904

250,135

202,920

229,396

176,549

191,787

151,552

146,873

136,874

136,810

127,928

131,938

128,117

124,019

116,649

107,846

113,425

110,631

109,456

101,614

97,750

91,950

84,953

80,807

82,787

Collaborative agreement revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

131

342

376

-

353

506

415

1,140

1,754

889

135

226

1,210

423

96

93

97

153

125

175

130

176

201

648

868

OPERATING EXPENSES:
Cost of sales

111,374

95,899

96,949

77,436

89,182

75,019

78,893

79,019

82,333

75,995

59,480

56,305

50,006

64,147

50,738

51,617

43,118

48,043

34,904

38,063

30,998

38,321

29,920

31,210

22,816

17,270

28,054

22,567

20,500

26,532

24,619

23,574

17,105

21,519

22,445

19,263

20,796

20,469

18,003

14,401

17,412

14,970

19,848

Research and development

142,257

172,812

172,963

185,641

183,591

175,390

161,408

175,582

183,948

168,608

154,103

143,039

145,003

175,242

160,831

167,039

158,793

176,118

158,713

157,901

142,074

141,989

125,686

107,702

86,166

97,312

88,064

85,661

83,743

84,363

66,209

77,812

73,834

57,871

58,577

52,909

45,017

42,197

39,366

35,649

30,097

26,991

26,324

Selling, general and administrative

187,295

187,900

170,112

160,754

162,158

164,171

148,566

153,280

138,336

160,280

130,532

143,505

120,019

142,958

118,758

109,577

105,300

113,907

94,044

101,514

92,806

99,394

74,604

68,089

60,069

71,809

61,841

50,656

51,050

55,049

46,337

51,539

45,248

48,491

44,880

41,015

41,037

42,098

38,348

37,277

34,000

28,667

30,527

Intangible asset amortization and contingent consideration

15,677

16,994

17,063

20,286

19,765

6,782

18,580

10,227

13,202

20,375

3,760

13,411

8,925

7,365

9,654

-54,414

10,442

-40,653

3,116

16,945

2,902

8,448

2,636

3,668

8,957

11,853

9,639

-2,022

5,556

12,898

1,443

2,048

2,328

832

-3,040

3,324

312

200

3,972

1,580

654

46

1,775

Gain on sale of nonfinancial assets

59,495

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

599,118

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of intangible assets

-

-

0

15,000

-

-

0

20,000

-

-

0

0

-

-

-

-

-

-

-

-

-

-

67,500

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

397,108

463,605

457,087

429,117

454,696

391,362

407,447

398,108

417,819

300,258

347,875

356,260

323,953

389,712

339,981

872,937

317,653

126,617

290,777

314,423

268,780

288,152

165,346

210,669

178,008

199,183

187,598

156,862

160,849

178,842

138,608

154,973

138,515

129,281

128,942

109,863

107,162

104,964

99,689

88,907

82,163

70,674

78,474

INCOME (LOSS) FROM OPERATIONS

104,961

-9,162

4,010

-41,354

-53,951

-38,148

-15,741

-25,263

-44,372

58,047

-13,727

-38,812

-20,208

-89,621

-60,085

-572,806

-80,917

101,319

-81,873

-64,288

-65,860

-58,756

11,203

-18,882

-26,456

-52,310

-50,724

-20,052

-32,921

-46,904

-10,491

-30,954

-21,866

-21,435

-15,517

768

2,294

-3,350

-1,939

3,043

2,790

10,133

4,313

Equity in the loss of BioMarin/Genzyme LLC

-77

193

-551

-44

-185

-46

-468

-107

68

-295

-253

-220

-523

-164

-104

-135

-135

-278

-186

-203

-150

225

-225

-539

-338

-438

-147

-163

-401

-253

-336

102

-734

-609

-608

-667

-542

-797

-639

-864

-691

-680

-546

Interest income

5,244

5,211

5,340

5,899

6,298

5,690

6,338

5,569

5,234

4,822

3,976

2,983

3,072

2,926

1,633

1,357

1,571

1,451

1,344

1,023

683

1,644

1,435

1,735

1,123

1,141

574

650

718

765

778

536

505

632

722

798

782

919

968

1,035

1,190

1,012

886

Interest expense

6,915

6,930

2,937

6,866

6,727

7,746

12,131

12,225

11,562

11,664

10,884

10,040

10,119

9,732

9,980

9,944

9,843

9,333

9,447

10,002

9,462

9,197

9,118

9,221

9,106

7,593

526

603

1,725

1,930

1,837

1,925

1,947

1,877

2,168

2,201

2,163

2,746

3,008

2,635

2,429

2,880

4,404

Debt conversion expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

163

-

-

674

-

813

1,732

0

10,420

-

0

0

0

-

1,896

-

-

-

0

-

-

-

-

Impairment loss on equity investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Net gain from sale of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-25

0

0

927

0

1,585

Other income (expense), net

-1,861

907

3,960

470

1,608

-3,061

2,589

2,849

-172

3,688

267

543

3,472

4,425

1,723

-1,417

198

-357

-281

-9,073

249

-327

-74

-147

153

638

239

-123

228

-1,772

125

-176

36

173

-264

129

22

-

-

-

-

-

-

INCOME (LOSS) BEFORE INCOME TAXES

101,352

-9,781

9,822

-41,895

-52,957

-43,311

-19,413

-29,177

-50,804

54,598

-20,621

-45,546

-24,306

-92,166

-66,813

-582,945

-89,126

92,965

-90,443

-82,543

-74,703

-65,737

3,221

-27,728

-34,624

-59,375

-52,316

-20,291

-44,521

-50,094

-11,761

-32,417

-24,006

-23,116

-19,731

-1,173

393

-19,238

-4,618

579

1,787

7,585

1,834

Provision for income taxes

19,971

-24,805

-45,214

-4,460

3,516

-39,661

-6,793

-12,385

-6,655

105,990

-8,094

-8,713

-8,016

-1,446

-29,388

-163,931

-6,075

24,348

483

-554

-7,202

4,060

-4,224

5,774

3,491

2,615

704

1,242

-4,711

2,918

-6,404

-411

-34

3,619

-2,078

3,904

4,764

-7,049

-221,952

1,056

636

945

522

NET INCOME (LOSS)

81,381

15,024

55,036

-37,435

-56,473

-3,650

-12,620

-16,792

-44,149

-51,392

-12,527

-36,833

-16,290

-90,720

-37,425

-419,014

-83,051

68,617

-90,926

-81,989

-67,501

-69,797

7,445

-33,502

-38,115

-61,990

-53,020

-21,533

-39,810

-53,012

-5,357

-32,006

-23,972

-26,735

-17,653

-5,077

-4,371

-12,189

217,334

-477

1,151

6,640

1,312

Earnings Per Share, Basic and Diluted (in dollars per share)

-

-

-

-0.21

-

-

-

-0.09

-

-

-0.07

-0.21

-

-

-

-2.58

-0.51

-

-

-0.51

-0.43

-

-

-

-

-

-

-

-

-

-0.04

-

-0.21

-0.23

-0.16

-0.05

-0.04

-

-

-

0.01

-

-

NET INCOME (LOSS) PER SHARE, BASIC (in dollars per share)

0.45

-

0.31

-

-0.32

-

-0.07

-

-0.25

-

-

-

-0.09

-

-0.22

-

-

-

-0.57

-

-

-0.48

0.05

-0.23

-0.26

-

-0.38

-0.15

-0.31

-

-

-0.27

-

-

-

-

-

-

2.13

0.00

-

0.07

0.01

NET INCOME (LOSS) PER SHARE, DILUTED (in dollars per share)

0.44

-

0.30

-

-0.32

-

-0.07

-

-0.26

-

-

-

-0.09

-

-0.22

-

-

-

-0.60

-

-

-0.47

0.05

-0.23

-0.27

-

-0.38

-0.16

-0.31

-

-

-0.27

-

-

-

-

-

-

1.68

-0.01

-

0.07

0.01

Weighted average common shares outstanding, basic (in shares)

179,898

179,548

179,289

179,048

178,271

177,958

177,481

176,873

175,932

-

-

-

172,710

-

167,714

-

-

-

160,886

-

-

148,277

147,016

146,120

143,983

-

140,796

139,400

127,969

-

-

117,912

-

-

-

-

110,652

107,406

102,110

101,712

101,144

100,331

100,065

Weighted average common shares outstanding, diluted (in shares)

187,163

-

185,924

-

178,271

-

177,481

-

176,150

-

-

-

172,710

-

167,714

-

-

-

161,134

-

-

135,584

159,304

146,351

144,157

-

140,796

139,596

127,969

-

-

117,912

-

-

-

-

110,743

165,864

131,278

101,834

103,720

101,815

101,217

Weighted average common shares outstanding, basic and diluted

-

-

-

-

-

-

-

-

-

-

175,103

174,374

-

-

-

162,587

161,548

-

-

160,406

157,612

-

-

-

-

-

-

-

-

-

123,434

-

115,070

-

112,290

111,114

-

-

-

-

-

-

-

COMPREHENSIVE INCOME (LOSS)

95,344

-

74,600

-39,790

-41,950

-

-13,651

10,624

-49,147

-

-19,303

-56,511

-24,086

-

-39,795

-414,533

-104,037

-

-98,203

-93,347

-51,148

-

16,693

-30,836

-35,858

-

-43,988

-20,247

-38,453

-

-7,674

-29,868

-26,347

-

-10,426

-5,213

-10,346

-

-

-

-

-

-

Net product revenues
Total revenues

489,043

436,585

450,900

379,075

394,483

347,151

386,320

367,786

369,099

353,577

298,752

315,926

302,190

298,186

278,262

298,576

235,357

226,420

207,767

249,023

201,312

227,752

173,416

188,244

149,004

144,286

134,330

132,400

127,344

130,957

126,310

122,991

116,239

106,064

112,891

109,616

109,076

98,477

96,559

90,592

84,073

78,383

81,472

Royalty and other revenues
Total revenues

13,026

17,858

10,197

8,688

6,262

6,063

5,386

5,059

4,348

4,728

35,396

1,522

1,555

1,905

1,634

1,555

1,379

2,365

1,006

770

1,232

2,918

2,780

3,037

2,133

1,447

790

3,521

449

755

597

605

314

1,689

437

862

255

2,962

1,061

1,182

679

1,776

447